MXPA99006205A - Controlled coverage additive application to paper tissue - Google Patents

Abstract

A soft tissue product (44) includes deposits of a surface additive composition disposed in primary (46) and supplementary (48) delivery zones having different add-on levels. The supplementary add-on level is greater than 0 and less than the primary add-on level. For example, the supplementary add-on level may be from about 0.5 to about 80 percent of the primary add-on level. In particular embodiments, the primary delivery zones (46) cover from about 30 to about 90 percent of the tissue and the supplementary delivery zones (48) cover from about 10 to about 70 percent of the tissue. The different add-on levels effectively maximize consumer benefit while minimizing the total amount of additive on the tissue. One particularly beneficial method is to uniformly apply the composition to the surface of the tissue web within each of the zones by rotogravure printing, either direct or indirect (offset), because it is a very exact printing process and offers maximum control of the composition distribution and transfer rate. However, other applications methods, such as flexographic printing, spraying, extruding, and the like can also be used. An engraved roll (23A, 23B) suitable for use in applying additives to tissue paper (44) is engraved with two different regions (40, 42;50, 52) of cell patterns.

Description

APPLICATION OF CONTROLLED COVERAGE ADDITIVE TO PAPER TISSUE Background of the Invention Absorbent tissue products such as facial tissue and bath tissue have been used to absorb body fluids and leave skin dry. The frequent use of absorbent tissues may, however, tend to rub against the skin. In particular, during the frequent sounding of the nose, the skin rubs until it appears red and sensitive to the touch. To reduce this skin friction, the tissue products have included additives applied to the surfaces of the tissues to reduce or eliminate chafed skin during periods of heavy use. The additives can improve the perceptions of skin smoothness by reducting the stiffness of the sheet, making it more drapable or by providing lubricity, helping the sheet to slide across the surface of the skin. The additives can also be deposited on the skin.

So far, the general approach in the industry has been that the greater the amount of additive on the tissue, the greater the benefit. Contributing to this approach is the fact that particular additives can be absorbed into the tissue, leaving less additive on the surface to provide the intended benefit.

A main advantage of the "more is better" philosophy is the cost. Additives that target skin friction can represent a significant part of the cost of a tissue sheet. Also, for some additives, relatively high addition levels can be difficult to manufacture. Thus, there is a need for a tissue product that includes an additive adapted to improve sheet smoothness and / or reduce skin irritation and redness, wherein the additive is present in an economical but effective aggregate amount. There is also a need for a cost effective method for manufacturing a tissue product that includes such an additive.

Synthesis of the Invention It has now surprisingly been discovered that tissue products containing an additive adapted to reduce skin irritation and redness can be manufactured with essentially lower total aggregate amounts without diminishing the effectiveness of the additive. Applicants have found that an array of primary delivery zones with a relatively high additive aggregate amount in combination with complementary delivery zones with a relatively lower aggregate amount can be effectively used to maximize consumer benefit while minimizing the total amount of additive on the tissue.

In one embodiment, a tissue product defines a main surface having a planar surface area. The tissue product comprises an additive composition placed on the main surface in at least one primary delivery zone and at least one delivery zone. complementary The primary delivery zone has a primary aggregate level and the complementary delivery zone has a complementary aggregate level. The level of complementary aggregate is greater than zero and from about 0.5 to about 80% of the primary aggregate level.

In another embodiment, a tis product comprises an additive composition placed on the main surface in at least one primary delivery zone having a primary aggregate level-at least one complementary de-entry zone having a complementary aggregate level. The complementary aggregate level is greater than zero and the primary aggregate level is greater than the complementary aggregate level. The primary delivery zone covers from about 30 about 90% of the tissue surface area and the complementary delivery area covers from about 10 to about 70% of the tissue surface area.

The complementary primary aggregate amounts, and the number, size, shape and position of the primary and complementary delivery zones, can be selected to maximize the overall benefit provided to the consumer while minimizing the total aggregate amount. The terms "primary aggregate amount" and "primary aggregate level" refer to the basis weight of the additive composition in the primary delivery zone (s), typically measures in grams per square meter (gsm). In contrast, the terms "complementary aggregate amount" and "complementary aggregate level" refer interchangeably to the base weight of the additive composition in the complementary delivery zone or zones. Therefore, for any given tissue that includes a segmented surface additive composition in zones having different aggregate amounts, the zone or zone having the higher aggregate quantities are considered the primary delivery zones and the zone or zones having the quantities The supplementary delivery zones may be used on one or both of the tissue surfaces.

For the purposes of the present invention, the primary aggregate amount is generally established as the level of the selected additive that provides a high degree of satisfaction on the part of the consumer. The additional aggregate amount provides a lower degree of consumer satisfaction than the primary aggregate amount, but significantly, it still provides some degree of benefit. The actual basis weight values for the primary and complementary aggregate quantities may need to be determined by comparing the consumed benefits obtained from a series of test tissue products that differ from each other only in the aggregate amount of additive each having an application. uniform of the additive deposited on a surface or both surfaces. The primary added amount will be the same as or similar to the aggregate amount on the test tissue products that deliver the desired level of benefit to the consumer. The complementary aggregate amount will then be greater than zero but less than the primary aggregate amount.

The number, size, shape and position of the primary delivery zone or zones on a particular tissue are selected to obtain the same benefit essentially the same benefit to the consumer as would be obtainable from a tissue that has a uniform aggregate amount equal to the primary aggregate amount. One or more complementary delivery zones are provided on the tissue product so as not to diminish the benefit delivered by the primary delivery zones. The supplemental delivery zones allow a reduction in the cost of the tissue product and comparison to what would result if the total covered area included the additive composition in the primary aggregate amount. It is speculated that the "areas devoid of adhesive, that is, the areas on the surface of the tissue that do not contain the additive composition, significantly decrease the benefit provided by the primary delivery zone or zones." The combination of the complementary primary delivery zones is think that it allows the delivery of the benefit to the consumer allowed by the primary aggregate quantity but at the lowest cost.

By way of illustration, a single primary delivery zone may be centrally located on the surface of the tissue and comprise about 65% of the planar surface area of the tissue. A single complementary delivery zone can completely enclose the primary delivery zone and comprises about 35% of the planar surface area. In this embodiment, the primary delivery zone is located centrally to maximize the opportunity for the added primary aggregate amount of additive to make contact with the skin during product use to give maximum benefit. The complementary delivery zone provides some benefit in an important way does not take away the benefit derived from the primary delivery area. Such a tissue is believed to be capable of providing benefits to the consumer as compared to a tissue having an aggregate amount of uniform additive equal to the aggregate primary amount centrally located on 100% of the planar surface area, and at a reduced cost.

By way of further illustration, the tissue product may comprise an alternating pattern of primary and complementary delivery zones. This product is also capable of providing the consumer benefits associated exclusively with the higher aggregate amount, but at a reduced cost because the primary delivery zones tend to mask the additive reduction of the complementary delivery zones. Again, the placement of the complementary delivery zones on one side of the primary delivery zones does not reduce the benefits delivered by the primary delivery zones, as would otherwise be the case if the areas devoid of additive would take the place of the complementary delivery areas.

It should be readily appreciated that a wide variety of configurations of the number, size, shape, and position of the primary and complementary delivery zones are possible. The specific size of the primary delivery zones and the complementary delivery zones will depend on the desired effect of the composition and the specific composition.For example, in the course of blowing or cleaning the nose, the pressure is exerted against the tissue and the nose by the fingers. Therefore the size of the zones can be regulated by the dimension of a single finger or of several fingers used together to apply pressure while cleaning the nose. Ideally the regions of additive that give the most important benefit, which is the primary delivery zones will each have an individual zone size at least as large as those dimensions so that any contact point during cleaning the most important additive will will always be in contact with the skin. In addition, each individual complementary delivery zone will preferably have a smaller individual area size than that of the primary delivery areas and therefore smaller than the size of a single or multi-finger finger. Using the primary and complementary delivery zones, limited use of non-adhesive areas may be acceptable. Desirably, of course, the dimension of areas devoid of additives is incorporated into the design, it will be further reduced. - - - - ..- -. Using this as an example, a single primary delivery zone can desirably have a width dimension of from about 0.2 inches to about 5.5 inches, such as from about 0.2 to about 4 inches, more specifically from about 0.4 inches to about 2 inches and even more specifically from about 0. inches to about 1.5 inches. A single complementary delivery zone can desirably have a width dimension d from about 0.1 inches to about inches more specifically from about 0.2 inch to about 1 inch, and even more specifically from about 0.25 to about 0.75. inches If it is present at all, each area devoid of additive will desirably have a width dimension of from about 0.003 inches to about 1 inch, more specifically from about 0.008 inches to about 0.5 inches, and even more specifically from about 100 inches. 0.02 inches to about 0.2 inches. It should be noted that there may be conditions such as cost, clean-up task and the like that could change the size ratios of the area of deprived, primary and complementary area. The length dimensions of the primary and complementary delivery zones and the areas devoid of additive may extend over the complete tissue or only over part of the tissue. It is generally thought that it is desirable that the primary and complementary delivery zones be placed immediately on one side of each other. . Compas used herein, the term "immediately adjacent" refers to the complementary delivery zones that have at least one common boundary or limit, rather than being separated by an area devoid of additive. It is theorized that the effectiveness of the additive composition in the primary delivery zones is maintained to a greater extent when the primary delivery zones are placed on one side of the complementary delivery zones as opposed to the areas without adjacent additives.

The area coverage of the primary delivery zones, the complementary delivery zones, and the depleted areas will depend on the desired effect of the composition and the specific composition. The tissue coverage of the primary zones will generally be from about 30 to about 90%, more specifically from about 40 to about 80%, and more specifically from about 50 to about 75%, based on the simple planar view surface area of the tissue. The tissue coverage of the complementary areas will generally be from about 10 to about 70%, more specifically from about 20 to about 60%, and more specifically from about 25 to about 50. deprived that may be present will generally represent from about 0.5 to about 50%, more specifically from about 1 to about 25%, and even more specifically from about 1 to about 12%. Correspondingly, the primary and complementary delivery zones desirably have the combined surface area of at least about 50%, more particularly of at least about 75%, and even more particularly of at least about 88%. %, such as 100%, of the planar surface area. The coverage of the total tissue area of the primary delivery zones, of the complementary delivery zones, and of the hollow areas represents, by definition, 100% of the tissue surface area, based on the surface area of simple planar view .

Another aspect of the invention relates to a method for making a tissue product. The method comprises the steps of: providing a tissue of tissue and an additive composition; applying the additive composition to the tis fabric using a rotogravure process comprising a engraved roll having the primary and complementary regions, the primary and complementary regions being adapted to provide different aggregate rate; and recovering from the rotogravure process or tissue product having the additive composition placed on both the primary delivery zone having a primary aggregate level and a complementary delivery zone having a complementary aggregate level, with the complementary aggregate level being greater than zero and from about 0.5 to about 80% of the primary aggregate level. _. . - A particularly beneficial method is to uniformly apply the composition to the surface of the tissue tissue within each of the areas by rotogravure printing, either directly or indirectly (offset), because it is a very accurate printing process and offers a maximum control of the composition distribution and the transfer rate. However, other application methods, such as flexographic printing, spraying, extrusion, the like can also be used.

As is typical of printing by engraving, the additive composition in each of the primary and complementary delivery areas may actually be present in a large number of small spaced and spaced deposits on the surface of the tissue. These deposits are desirably placed uniformly within each zone but only cover part of the surface in each zone. When viewed by the naked eye, the larger number of small spaced and separated deposits appear to cover the entire surface, but in fact they do not. The coverage of the actual surface area of the deposits can be from about 30 to about 90%, more specifically from about 50 to about 80%. For the purpose of the present invention, the surface areas of the primary and complementary delivery zones include the entire area circumscribed by the deposit pattern, and not just the coverage of the actual surface area of the deposits.

Etch printing is ideally suited for such application by providing, for example, from about 10 to about 1,000 deposits per linear inch of surface, or from about 100 to about 1,000,000 of deposits per square inch. Each deposit results from an individual cell on the printing roller, so that the density of the deposits corresponds to the density of the cells. The engraving printing encompasses various known engraving techniques, such as mechanical engraving, acid etching, electronic engraving and ceramic laser engraving. A suitable exemplary electronic engraving for a primary delivery zone is about 200 po deposits per linear inch of surface, or about 40,000 deposit per square inch. By providing such a large number of small deposits, the uniformity of the deposit distribution is very high. Also, because the large number of small deposits applied to the surface of the tissue, the deposits are more easily resolidified on the tissue surface where these are more effective to benefit the user. As a consequence, a relatively low amount can be used. of the composition to cover a large area.

The rate of addition is also determined by the volume of roller engraving. Typically, this is expressed in terms of the volume of the cells per square inch of the recorded area. The volume in the primary delivery regions will deliver more additive composition than the volume in the complementary delivery regions. The liquid cell volume range for a primary delivery region, described in cubic trillion cubic terms (CBM) terms per square inch is suitably from about 0.5 to about 15 CB per square inch, more specifically from about d 1 to about 10 CBM per square inch, and even more specifically from about 1.5 to about 8 CB per square inch. The range of liquid cell volume for a complementary delivery region is suitably from 0.1 to about 10 CBM per square inch, m specifically from about 0.5 to about 8 C per square inch, and even more specifically from around from 0.75 to about 6 CBM per square inch.

The composition or additive compositions can be applied to one or both of the outer tissue surfaces. The additive composition may be water based or oil based. Suitable water-based compositions include but are not limited to emulsions and water dispersible compositions which may contain, for example, desaglutinant (cationic, anionic or non-ionic surfactants), or polyhydroxy compounds such as glycerin or propylene glycol. The ba sheet can be treated with a bicomponent system comprising binder and a polyhydroxy compound. Both components can be added separately or mixed together before being applied to the base sheet. In particular embodiments, the primary and complementary delivery zones on opposite sides of the tissue may comprise different additive compositions.

In particular embodiments, the tissue products are made by applying, on the surface tissue surfaces, large numbers of individual deposits of a melted protective / humidifying additive composition comprising a wax and an oil, and then resolidifying the composition to form a distribution of solid deposits on the surface or surfaces of the tissue. Because the composition is a solid at room temperature and solidifies rapidly after deposit, it has less tendency to penetrate and migrate into the sheet. Compared to tissues treated with liquid formulas, it leaves a greater percentage of the aggregate composition on the surface of the tissue where it will contact and / or transfer to the user's skin to provide a benefit. In addition, a lower aggregate amount may be used in both the primary and complementary zones to deliver the same benefit at a lower cost due to the efficient placement of the composition essentially on the surface of the product.

The additive composition may comprise solidified deposits of a composition comprising from about 30 to about 90% by weight of the oil, and from about 10 to about 40% by weight of wax, preferably also containing from about 5 to about 40% by weight of fatty alcohol, said composition having a melting point of from about 30 ° C to about 70 ° C, more specifically from about 40 ° C to about 60 ° C. For the data purposes here, the "melting point" is the temperature at which most melting occurs, recognizing that the melt currently occurs over a range of temperatures.

The amount of oil in the composition can be from about 30 to about 90% by weight, more specifically from about 40 to about 70% by weight, and even more specifically from about 45 to about 60. % by weight. Suitable oils include but are not limited to the following classes of oils: petroleum or mineral oils, such as mineral oil and petrolatum; animal oils such somo as ermine and lanolin aseite; plant oils, such as aloe extract, sunflower seed oil and avocado oil; and silicone oils, such as dimethicone and alkyl methyl silicones.

The amount of wax in the composition can be from about 10 to about 40% by weight, more specifically from about 10 to about 30% by weight, and even more specifically from about 15 to about 25. % by weight. The adasudas seras include, but are not limited to the following classes: natural waxes, beeswax and carnauba wax; petrolatum waxes, such as paraffin wax and ceresin; the silisone seras, such somo siloxanes of methyl alkyl; or synthetic waxes, such as synthetic beeswax and synthetic sperm wax.

The amount of fatty alcohol in the composition, if present, can be from about 5 to about 40% by weight, and most densely from about 10 about 30% by weight. Selflessly the fatty alcohols also include the alcohols that have a carbon chain length of C 4-C30, including acetyl alcohol, stearyl alcohol, behenylic alcohol and dodecyl alcohol.

In order to further improve the benefits to the users, additional ingredients may be used. The classes of ingredients and their corresponding benefits include, without limitation, also C10 or higher fatty alcohols (lubrisidad, suerpo, opasidad), fatty esters (lubrisidad modifisasión of sensasión); vitamins (topical medical benefits); Dimethicone (skin protection); powders (lubricity oil absorption, skin protection); antioxidant preservatives (product integrity); ethoxylated fatty alcohols (wettability, auxiliary substances); fragrance (attraction to the consumer); lanolin derivatives (skin moisturization); dyes, optical brighteners, skin creams, alpha hyy acids, extracts of similar natural herbs.

The additive somposission given above may be apieced to one or both of the outer surfaces of the tis by venting the deposition at a temperature above the melting point of the somposission. For example, a melted point d from around 30 ° C to around 70 ° C thus causing the somposission to melt. The additive is then evenly apicalized within one or both of the primary and somplementary zones to the predetermined aggregate sanctities for such zones by uniformly apllying the melted somposission to one or both superfishe of a tissue of tissue in spaced-apart reservoirs. Afterwards, the deposits of the melted composition are resolidified. The resolidifisation of the deposits can occur instantaneously, without the need for external cooling means such as cooling rollers, if the somposission is released at a temperature only slightly above or at the melted point of the somposission. However, external cooling media such as coolant rollers, either "before after the application of the melt, can be used if desired to accelerate the resolidification." Such instant resolidifisasio tends to impede the penetration of the composition inside. of the tissue and retaining it on the superfisies the tissue is advantageous.For example, the temperature of the melted composition may advantageously be above the melted point of about 10 ° C or less, more densely about 5 ° C or less, and even more specifically at about 2 ° C or less.When the temperature of the melted composition approaches the melting point, the viscosity of the melted composition generally increases, which further improves the tendency of the melted composition to be retained on the surface.

The additive superfamily sompositions of the foregoing type which comprise a sera and a subject are disclosed in International patent application PCT / US96 / 01243 published on August 15, 1996 and identified as WO 96/24722; an International patent application PCT / US96 / 01297 published August 1, 1996 identified as WO 96/24723; whose descriptions are insorporated here by referensia.

The aggregate amount of the additive composition to total tissue represents the. added complementary primary sanctities combined and can be from about 1 around 40% by weight., more espesífisament -from about 3 to about 15% by weight, and even more espesifistamente from about 5 to about 10% by weight, based on the weight of the tissue. The aggregate sanctity for "each of the primary and complementary delivery zones will depend on the desired effect of the composition on the attributes of the produsto and the espesífisa somposission., however, with respect to the additive composition of the above type involving a sera and an aseite, the primary aggregate sanctity is adesuadament of from about 1 to about 35% by weight, more specifically from about 3 to about 15% po weight, and even more specifically from about 4 around 10% by weight, based on the weight of the tissue. In addition, the aggregate sum amount is adesitably from about 0.2 to about 28% by weight, more specifically from about 0.5 to about 12% by weight, and even more specifically from about 1 to about 8% by weight, based on the weight of the tissue. In relation to each other, the aggregate amount of somatic for an additive somposision which comprises a sera and a sachet is preferably from about 0.5 to about 80%, more specifically from about 5 to about 70, and even more specifically from about 15 to about 50%, of the primary aggregate amount.

The presence of the additive composition comprising a wax-and a. oil and the diferennsias- in sanctities added in the various zones of the tissue, it can be verified by the image analysis of the superfisie or superfisies the tissue after the treatment is the osmium tetroxide to manshar the aggregate composition. The uniformity of osmium-stained tissues within each of the primary and complementary delivery zones can be considered by a variation coefficient of about 15 or less, more specifically about 10 or less, and even more specifically from around 5 to around 15. The degree of penetration. Or lack of penetration of the most stained composition with osmium can be characterized by a major gray level difference between the opposite sides of a single stratum the GLDJPERENC ^ tissue (hereinafter defined) of around 5 or greater, more densely around of 10 or greater, and more espesifistamente of from around 5 to around 15.

The osmium tetroxide manshade treatment used to measure the uniformity and penetration of the somposis is carried out by placing the tissues loosely in a glass jar jar having an opening diameter of about 12-16. inches and a depth of about 12 inches. You should be careful not to stack the tissues, which could impair the adequate penetration of the vapors into the tissues. The osmium tetroxide has received a crystalline solid in a sealed vial of glass, it is broken to open it, and it is poured into the bell jar with the tissues. The upper part collects on the sampana glass jar forming an air-tight seal. The tissues remain in the bell jar for about 2 to 48 hours. Osmium tetroxide has a high vapor pressure and is quickly sublimated to a gas which permeates the bell jar chamber. After the manshado is completed, the sampana jar opens and the samples are allowed to air for 1 to 24 hours before handling to release any residual non-reassured vapors. Note: care must be taken when using osmium tetroxide, this is a powerful and highly toxic oxidizer. All the procedures with this material should be carried out in a subsite d smokes are a flow of adesuado air.

In order to measure the length of several samples, the treated sheet is osmium with a unidirectional dark camp light produced by an octagonal ring illuminator of 8 bulbs surrounding a 5-millimeter EL-Ni kor lens attached to a tube of extension of C-frame of 1 mm. This is the input to a Quantimet 970 image analysis system (from Leica, Deerfield, Illinois), using a calnicon scanner, the field size (standard live frame) is 2.77 centimeters by 2.17 centimeters, or adjusted to be more small to accommodate the primary or secondary areas d form more stress - Several fields of the sample of tissue treated with osmium under the lenses are solosados and measured using a black photo-bottom. A total of 6 sampras were measured. The white level of the scanner is always set to 1.00 volts. For this purpose, the histogram was printed and the standard deviation was divided by its main gray level is the coefficient coefficient d. When multiplied by 100, this was expressed in the form of a multiple statement.

In order to determine the difference of the main gri level, the optical and image formation used are the same as described above for the measurement of uniformity, but in this case, the upper and lower surface parts of the The stratum of tissue was tightly knit one close to the other to form a "jun de cola" without a separation between the two pieces. The sample was placed under the lenses with, for example, the piece with the lightest background surface on the top of the image and the upper surface piece on the left side of the image sub-frame.

If by first measuring the gray level histogram the background surface is more slate, the variable live subframe is just above that region of the image frame, with the white level scanner set to 1.00 volts of the whole cam. Then the sample was rotated so that the more slaty bottom surface is now on the left. The scan was adjusted to 1.00 volts and this superfis is new, isolated by the variable live frame. These data are assumed in the same gray level histogram. The grins level of the GLFONDQ background surface was recorded.

The same procedure is then carried out on the upper surface plus the other half of the image, again the explorer level is blasting at 1.00 volts for the full image. This will tend to sompens by the overall difference in the amount of composition added to the tissue, while focusing more adequately on whether the composition is on the upper or lower surface, which reflects the degree of penetration. Again, the prismatic level of the upper surface, GLSUPER-OR, was recorded.

Finally, the difference between the two gray levels, GLUJPERENCE. it was classified as a value inversely related to penetration: CLDIFERENCIA - CL ONDO - GL SUPERIOR Note that if it is zero or negative, full penetration has occurred. If it is highly positive, then most of the manshada somposission is osmium is settling on the superior surface of the tissue.

The additive somposistion can alternatively include a silicone compound. Suitable silicone compounds are those silicone compounds which provide a lubricious and smooth surface feel preferably without smearing the glass. Preferably the silisone coatings are present in an aqueous emulsion and / or in a solder for ease of handling and processing. A wide variety of such silicone compounds are found in the art. Specifically suitable silicone compositions include, without limitation, the polydimethyl siloxanes; the mixture of polydimethyl siloxanes and of polydimethyl siloxanes modified with alkylene oxide; the organomodified polysiloxanes; the mixtures of dimethyl siloxane, sisylis and non-slishy modified; and similar. The number average molecular weights are usually around 10,000 or greater. Also suitable are aqueous mixtures of tetraethoxysilane, dimethyl diethoxy silane and dimethyl siloxane / ethylene dye copolymer. A preferred composition contains about 5 by weight of tetraethoxysilane, about 5% by weight of dimethyl diethoxysilane, and about 2% by weight of d-dimethylsiloxane / ethylene oxide copolymer in water. In such silane mixtures, the dimethyl siloxane-ethylene oxide acts as a coupling agent to bind the silisone to the tissue sheet surface, thereby delaying the assumption of residue on the contaste surface and thereby reducing the associated fatty sensation. with some lubricants.

The additive surface compositions of the above type comprising a silicone compound are described in U.S. Patent No. 4,950,545 issued August 21, 1990 and in U.S. Patent No. 5,227,242 issued May 13, 1993. , both granted to Walter and others; the insults of the suals are insorporated here by referensia.

The total sanity of silisone solids in the tissue sheet can be from about 0.1 to about % by weight, based on the finished basis weight of the tissue sheet. Preferably the amount of silicone compound is from about 0.5 to about 3% by weight and more preferably from about 0.7 to about 2% by weight. The amounts below 0.1% by weight alone provide a beneficial effect to the fascial tissue in terms of improvement of softness. Sanctities above 5% by weight can be made not unacceptably stubborn.

The primary aggregate sanctity of the additive composition comprises a silicone compound and suitably is from about 0.1 to about 5% by weight, more specifically from about 0.5 to about 3% by weight, and even more espesifly from from about 0.7 about 2% by weight, based on the weight of the tissue. In addition, the added aggregate sanctity of a composition-adding a silisone composition is suitably "from" about 0.05 to about 3.5% by weight, more specifically from about 0.25 to about 1.75 by weight, and yet more espesifistamente of from around 0.35 around 1% by weight, based on the weight of the tissue. Erelated to each other, the complementary aggregate amount for a composition composition of silicone compound and preferably from about 0.5 to about 80%, more specifically from about 5 to about 70%, and more especially from from about 15 to about 50 of the primary aggregate amount.

The presensia of the additive composition composed of silicone and the differences in the sanctity aggregate in the various areas of the tissue can be seen mediant thickeners infrared and X-ray fluorescence.

The silisone compound can be incorporated into the facial tissue by any suitable means, including printing, rossing, embedding and the like. The silicone compound can be incorporated into the tissue sheet at any point in the tissue manufacturing process. Preferably the silisone pack is printed on a tissue sheet between the tissue sheet dressing process and the final tissue manufacturing process. The impression provides a d presiso of the added sanctity of the solitary silisone sompone to the silisone material - on the surface of the tissue in the primary and complementary zones selected to maximize its effectiveness.

The tissue product of this invention may be a stratum, of two strata, of three strata or more. In all cases, the additive composition is desirably applied to the surface or outer surfaces of the product. The composition can be applied after the layers are put together before putting the strata together, The individual strata can be in sapas or without sapas (homogeneous), they can be srepados or not creped and compressed in humid, dried in continuous form or similar. In partiscular incorporations, the tissue product comprises one or more sessed tissue layers in a non-splayed sontinuous shape.

For the purposes herein, the "tissue sheet" is a single stratum sheet suitable for a facial tissue, bath tissue, towels, napkins, or the like having a density d from about 0.04 grams per cubic centimeter to about 0.3. grams per cubic centimeter and a base weight of desd about 4 to about 40 pounds per 2880 feet added The retention resistances in the machine direction is in the range of from about 100 to about 5,000 gram per inch of ansho . The tensile strengths in the transverse direction of the machine are in the range of about 50 to about 2,500 grams per inch of width. The cellulosic tissue sheets of the paper fibers are preferred, even though they may be present synthetic fibers in significant quantities.

Brief Description of the Drawings Fig. 1 is a schematic process flow chart for a method for making a creped tissue base sheet as it would be in preparation for printing out of the heated supply line.

Fig. 2 is a schematic process flow diagram for a method of this invention in which the parent rolls of the continuously dried and non-creped tissue are treated on one side using an off-line direst die-cut printing process.

Figure 3 is a schematic display of a heated direct rotogravure process in which the melted somposission is applied to both sides of the tissue.

Figure 4 is a further schematic description of a method of this invention in which both sides of the tissue product are printed are the melt composition using a combination of gravure printing and a rotogravure printout heated.

Figure 5 is a schematic depiction of a method of this invention in which both sides of the tissue simultaneously printed are the melted composition using the heated off-center rotogravure printing.

Figure 6 is a further schematic description of a method of this invention in which both sides of the tissue sheet are consecutively printed with the melted composition using the off-center and heated rotograbad print.

Fig. 7 is a schematic diagram showing a process for making a tissue sheet dried in a non-stenciled manner and flattening the sag deposited during the manufacturing process using a heated rotogravure printer according to this invention.

Fig. 8 representatively shows a plan view of an exemplary engraving roller for use in the manufacture of tissue products.

Fig. 9 representatively shows a tissue product manufactured using the engraved roller of Fig. 8 and treated with osmium tetraoxide to stain the additive composition black.

Fig. 10 representatively shows a plan view of another exemplary engraved roller for use in the manufacture of tissue products.

Fig. 11 representatively shows a tissue product manufactured using the engraved roller of Fig. 10 and treated with osmium tetrdxide for manshar of black additive somatization.

Detailed Description of Preferred Additions Referring to Figure 1, a method to carry out this invention will be described in greater detail. FIG. 1 discloses a process for making tis-based sheets suitable for off-line application of the heated additive compositions, and in particular a process for making continuously dried and non-creased base sheets suitable for off-line application of the additive somatizations salted. A twin forming wire is shown having a layered papermaking sheet 1 of papermaking or injecting a stream of an aqueous suspension of papermaking fibers onto a forming fabric 2. The resultant fabric is then transferred to a sheet of paper. which moves around a forming roll 3. The cloth 4 serves to bring the newly formed moist fabric downward in the process as the fabric is partially dewatered at a sonication of about 10% by weight. The additional drainage of the wet fabric can be carried out in a manner such as by a difference in air pressure while the wet fabric is supported by the forming fabric.

The wet fabric is then transferred from the fabric 4 to the transfer fabric 6 by moving at a slower speed than that of the forming fabric in order to impart a stretch in the direction of the machine augmented into the fabric. The kiss transferensia is worn to avoid the pressure of the wet fabric, preferably they are the help of a shoe of vasio 5. The fabric is then transferred from the transfer fabric to a cloth of sesado sontinua 8 are l help of a Transferensia roller with vacuum 7 or a transfer shoe with vacuum. The continuous drying fabric can be moved at about the same speed or at a different velosity to the transfer fabric. If desired, the continuous drying fabric can run at a slower speed to further improve the stretch in the machine direction. The transfer is then carried out in a vacuum to assure the deformation of the sheet to conform to the continuous sound cloth, thus giving volume, flexibility, stretching in the transverse direction and desired appearance.

The level of vacuum given for tissue transfers can be from about 3 to about 15 inches of mercury (75 to about 380 millimeters of mercury), preferably about 10 inches (254 millimeters) of mercury. The vault shoe (negative pressure) can be supplemented or replaced by the use of positive pressure from the opposite side of the fabric to blow the fabric onto the next fabric in adisitn or as a replacement for the slinging on the next fabric are vane. Also a roller or rollers with vasio can be used to replace the zapata or zapatas are vasío.

While held by the dried cloth in a continuous form, the fabric is dried in final form at a 94% greater consistency by a sonicate presser 9 and then transferred to a top carrier cloth 11 by moving around the roll 10.

The resulting dried base sheet 13 is then transported between the lower upper transfer fabrics, 11 and 12 respectively, to a sarret 14 where it is wound on a roll 15 for the substep printing of the salted additive printing and the additional sonication. . i5í- _ -._. :; ...-. - = .- - ----- - • • -. Figure 2 describes off-line printing in which the printing operation is carried out independently of the tissue sheet manufacturing process. The sheet that is being printed is the somposission aditiv. melted can be of unitary stratum or can be of multiple stratum. A roll 20 is shown on the roll to be treated that is being unwound. The tissue sheet 21 is passed to a heated rotogravure printing stock comprising a backing roller 22 and an engraving roller 23 at which point the composition of the treatment is applied to a surface of the tissue. The resulting sheet is then rolled up into a roll 24 for additional sonication operations.

During the printing operation, the melted composition to be applied to the tissue sheet is supplied by a heated supply tank 25 and pumped to a heated doctor application head 26 by means of a suitable dosing pump. It is desirable to maintain the constant temperature in the process. Therefore, the melted composition can be gently mixed between the supply tank and the aplissation test while maintaining a suitable sanctity in the tank. The dosed dosing head of the dispenser supplies the melted composition to the engraved roller 23, the surface of which contains a plurality of small cells in groups to form the zones-of-complementary primary delivery on the final tissue product. As previously noted, the configuration and aggregate rates of the primary and complementary zones are selesioned to provide the volume of transfer necessary to achieve the desired tactile effect. The engraved roller 23 will be eliminated in greater detail from now on in relasió? to figures 8-11 In operation, the engraved roll 23 is loaded onto the backing roller 22 to force the tissue sheet or tissue to counter the engraving roll. The backing rod may be of any material that satisfies the requirements of the process such as natural rubber, synthetic resin or other compressible super fi cials. The loading pressures may vary from approximately 5-50 pounds per linear inch (roller-to-roller interferensia) to a separation of backing roll / rotogravure roll from 0.008"inches (without roll-to-roll contact).

Figure 3 is similar to Figure 2, but illustrates printing by direct rotogravure of two sides of the sheet using two printing stations in sesuensia. Two-sided printing is desirable when the effect of the composition is on both sides and / or the tissue sheet consists of two or more layers.

Figure 4 depicts the printing of two side of the tissue sheet using a rotograbad printing method offset on one side of the sheet and a rotogravure printing method heated directly on the other side of the sheet. In this method, the engraving roller 23 and the backing roller 22 (now doubling as an offset applicator roll) can be the same as the rolls used for the previously described method. However, a second engraving roller 30 requires different liquid delivery faces, so it is recorded slightly differently. For such rollers, for example, the engraving thicknesses found for the primary delivery zones may show to be a rejill of 200 lines, 5.0 BCM. Typical cell dimensions for such a roller may be 150 yards long, 110 yards broad d, and 30 microns deep. The density engraving d offset for the primary delivery areas can be a grid of 250 lines, 4.0 BCM, 140 microns in length, 110 microns wide, and 26 microns deep. The engraving specifiations for the delivery zones can be adapted to provide relatively lower aggregate sanctities.

Figure 5 depicts a method of printing both sides of the sheet using the simultaneous unsealed de-etched gravure printing.

- Figure 6 represents - a method for printing both sides of the sheet in succession using two heated off-center rotogravure printing stations. For each printing station, the admission of a backup roller 31 is necessary.

Figure 7 is similar to Figure 1 exsept because the base sheets sewn 13 are transported to a printing step of gravure rotogravure shadowing the backing roll 22 and the engraved roll 23, at which point the composition of additives is applied to a superfisie of the leaf. The sheet of tissue sewn in a non-scrimped and treated form is then wound on a roll 15 for subsequent conversion operations.

An exemplary etched roller 23A suitable for use in applying additives to the facial tissue in areas of different aggregate amounts is shown in Figure 8. Engraving roll is etched with two different regions cell patterns. A primary region 40 has a grid lines of 200 cells per linear inch. Each cell has a volume of 5.08 trillion supershores (BCM) per supeed flea of roller surface, the typical dimensions being 180 misras in length, 143 ansho masks, and 30 misras depths. The resulting additive deposits are approximately 2.2 grams per supered meter. The primary region 40 is laterally surrounded by a pair of bulk regions 42. The complementary regions 42 each u have a line grid of 390 cells per inch line The cells in the complementary regions 42 have a volume of 1.5 BCM per square inch of surface of roll and l typical dimensions of 110 micras in length, 65 micras wide, and 18 micras in depth. The additive deposits q result from the complementary regions 42 are approximately 0.42 grams per square meter.

The combined regions 40 and 42 represent print coverage width of the facial tissue, approximately 8.5 inches. The primary region 40 is col- lapsed in the first 5.5 inches of the tissue and accounts for approximately 65% of the planar surface area of the tissue. The complementary regions 42 of each 1.5 inches wide and cumulatively cover approximately 35% of the planar surface area.

Fig. 9 representatively shows a facial tis 44 which will result from using the engraved roller 23A of Fig. 8. The tissue 44 is illustrated as having been treated with osmium tetradxide to stain the black additive composition. The result of the treatment shows a central primary delivery area 46 which is a darker shade than a pair of laterally spaced complementary delivery zones 48. In figures 9 and 11 the darker shading is illustrated by cross-sectional grid lines spaced further closely. The darker shading indicates the presence of more additive in the primary delivery area 46 than in the complementary delivery zones 48. The primary delivery zone 46 is centrally located to maximize the opportunity for the additive to make contact with the user's skin. . The complementary delivery zones 48 are uniformly coated with the same additive which is present in the primary delivery zone but at a reduced amount. This allows the complementary delivery areas to provide some benefit but more importantly does not drastically remove the benefit delivered by the primary delivery zone. In an incorporation, ti 44 does not include areas devoid of additive, since it speculates that such depleted areas when used as an alternative for complementary delivery zones significantly decrease the effectiveness of the primary delivery zone.

Figure 10 shows another engraved roller example 23B suitable for use to apply additives to the facial ti in the different transfer zones. The engraved rodil includes an alternating pattern of two different regions of selda patterns. A plurality of primary regions deliver additive deposits at approximately 2.2 grams per square meter and a plurality of complementary regions deliver additive deposits at approximately 0.42 grams per square meter. These regions 50 and 52 have the same line grid, cell volume and dimensions, respectively, q those described in relation to the primary secondary regions 40 and 42 of Figure 8.

The combined regions 50 and 52 of the figure have a print coverage width of about 8. inches. The seven primary regions 50 are each approximately 0.75 inches wide, and cumulatively cover approximately 62% of the planar surface area of the tissue. The eight complementary regions 52 are ca one of 0.41 inches wide and cumulatively cover approximately 38% of the planar superfamily area.

Fig. 11 representatively shows a fasial tis 54 which will result from using the engraved roller 23B of Fig. 10. The tissue 54 is illustrated as having been treated with osmium tetraoxide. The tissue includes seven different primary delivery zones 56 that appear darker than eight complementary delivery zones 58. The primary delivery zones tend to mask the reduced amount of additive in the delivery zones. The placement of adjacent complementary delivery areas and laterally outward d the primary delivery zones maintain the benefits resulting from the primary delivery zones. _._ .- .-. Although Figures 8 and 10 both show the veined areas that are continuous in one direction, it is possible to obtain changes in the additive rate of additive using different methods. For example, a block, circle or other shaped zon can be entered to repeat at specific intervals.

Examples The following examples serve to illustrate the possible approaches pertaining to the present invention. Particular amounts, proportions, composition and parameters are intended to be exemplary and are not intended to specifically limit the scope of the invention.

Example 1 A moisturizing formula of the skin q has the following composition: For I feel for Weight 1. Dimethicone 100 cst 1.0 2. Isopropyl palmitate 3.0 3. Vitamin E acetate 0.1 4. Aloe extract 0.1 5. Mineral oil - - -_- • 59.8 6. Ceresin wax (M.P. 66 71 ° C) 18.0 7. Cetearyl alcohol 18.0 The formula was prepared by pre-mixing dimethisone and isopropyl palmitate until they were uniform. While it was heated, the aloe vera extra and the extrac of vitamin E were added and mixed. The mineral oil added and the formula was mixed until it was uniform. The mixture was further heated to a temperature of 55-60 ° C. Ceresin wax was added. The mixture was further heated to 60-65 ° C with stirring until the ceresin wax melted. The setearyl alcohol was slowly added to the mixture while the agitation was maintained to avoid lumping. The temperature was maintained at about 55-60 ° C and the mixture was sonified until the cetearyl alcohol melted. At this point the formula was ready to be used.

The resulting formula was applied to both surfaces of a three-layer base tissue sheet (basis weight of about 23 pounds by 2880 square feet) through a simultaneous heated rotogravure printing process at an aggregate level of 6.8% by weight total of aggregate as described in relation to figure 5. Specifically, the formula was pre-melted at about 56 ° C in a heated stainless steel supply tank. The press and press supply system (supply hoses, doctor application heads and rotogravure rolls) were preheated to around 55 ° C. The formula was then transferred from the dispensing heads to the offset / offset rotogravure rolls.

The rotogravure rolls were etch-on-srometer rolls etched electronically supplied by Southern Graphics Systems, of Louisville, Kentucky. Each heated rotogravure roll included two different cell patterns as illustrated in FIG. 8. A centrally located primary region has a line grid of 200 cells per linear inch and a volume of 5.0 BCM per square inch of roll surface. The dimensions of typical selves for this rodill were 180 lengths, 143 ansho misters, and 3 depth misters. This primary region was laterally surrounded by a line grid of 390 sheets per linear inch and a volume of 1.5 BCM per square inch of roll surface. The typical dimensions of this roller were 110 lengths, 65 ansh and 18 depths. The style angle was set at 135 ° for the primary region and 145 ° for the complementary regions. The rubber backed offset applicator rollers were hardened polyurethane of 75 lasted Shore A supplied by the American Roller Company, of Union Grove, Wisconsin.

The process was set to a condition having 0.37 inches of interferensia between the rotogravure rollers and the rubber backing rolls, and a spacing of 0.003 inches between the opposed rubber backing rolls. The offset offset / offset offset rotogravure printer was subjected to a velocity of 2,000 feet per minute. The somposició deposits were solidified esensially instantaneously after leaving the press.

When sorted into individual tissue sheets, the resulting tissue product was directionally preferred by consumers for a global behavior on the somatic fascial tissues that have a generally uniform addition of additive at an aggregate level of 10.4% by weight of total aggregate. . Tissues insorporating the primary and somatic delivery areas also provided a significant cost advantage of uniform additive application tissues due to multiple-aggregate-level tissues including 35% less additive.

Example 2 The moisturizing formula of the dessrita skin in Example 1 was applied to both superfisies of a two-layer dried base sheet of ducts continuously (base weight of about 25 pounds by 2880 square feet) with an improved gravure printing. heated simultaneously to an aggregate-level of 8.6% by total weight of aggregate as described in Figure 5. Specifically, the formula was pre-drawn at about 56 ° C in a stainless steel saltwater supply tank. The press and the press supply system (supply hoses, dostor aplissability know-how, rotogravure rolls) were released at about 55 ° C. The formula was transferred from heated application heads to heated offset / offset rotogravure rolls. The rotogravure rolls and the rubber backing rolls were the same as described in example 1.

The process was put to a condision having 0.3 inches of interferensia between the rotogravure rollers and the rubber backing rollers, and a 0.0 inches spacing between the back and facing rubber rollers. The heated offset / offset rotogravure printer ran at a speed of 1500 feet per minute. The composition deposits solidified essentially instantaneously after leaving the press.

When cut into individual facial tissue sheets and tested by a consumer panel trained the resulting tissue product showed that it had comparable tissue softness qualities while being perceived as having better transmission, more absorption and improved resistenc when wetted when compared to non-creped continuous dried facial tissues having a generally uniform additive application at an aggregate level of 10.3% by total aggregate weight. Tissues insorporating the primary and somplementary delivery zones also provide a significant support advantage of uniform additive application tissues because multiple add level tissues include 16% less additive.

It will be appreciated from the foregoing examples, given for the purposes of illustration, that they should not be construed as limiting the scope of this invention, that it is defined by the following clauses and all equivalents thereof.

Claims (32)

R E I V I N D I C A C I O N S

1. A tissue product that defines a main surface having a planar surface area, the tissue product comprises an additive composition disposed on the main surface of at least one primary delivery zone having a primary aggregate level and therefore minus a complementary delivery zone that has a complementary aggregate level, the complementary aggregate level being May of zero, and from about 0.5 to about 80% of the primary aggregate level.

2. A tissue product defining a major surface having a planar surface area, the tissue product comprises an additive composition disposed on the primary surface in at least one primary delivery zone having a primary aggregate level and therefore less a zon of somplementary delivery that has a somplementary aggregate level, the level of somplementary aggregate is greater than zero, and the level of primary aggregate being greater than the level d supplementary aggregate, the primary delivery zone covers d from about 30 to about 90% of the planar surface area and the complementary delivery zone covers from about 10 to about 70% of the planar surface area

3. The tissue product, as claimed in clause 2, characterized in that the complementary add level is from about 0.5 to about 8 of the primary aggregate level.

4. The tissue product, as claimed in clauses 1 or 2, characterized in that the level of add-ons is from about 5 to about 70% d level of primary aggregate.

5. The tissue product, as claimed in clause 4, characterized in that the level of add-ons is from about 15 to about 50% d level of primary aggregate.

6. The tissue product, as claimed in clause 1, is characterized in that the zones between primary and somatic each comprise from about 100 to about 1,000,000 individual p-pits in excess of the planar superfamily area.

7. The tissue product, as such, is claimed in clauses 1 or 2, characterized in that the area between primary covers from about 40 to about 80% d planar surface area and the complementary delivery zone covers from around from 20 to about 60% of the planar surface area.

8. The tissue product, as claimed in clause 7, characterized in that the primary delivery zone covers from about 50 to about 75% planar surface area and the complementary delivery zone covers from about 25%. to about 50% of the planar surface area.

9. The tissue product, as claimed in clauses 1 or 2, characterized in that the primary and complementary delivery zones have a combined surface area of at least about 75% of the planar surface area.

10. The tissue product, as claimed in clause 9, characterized in that the primary and complementary delivery zones have a combined surface area of at least about 88% of the planar surface area.

11. The tissue product, as such, is claimed in Clause 9, which is sarasterized because the primary and secondary delivery zones have a surface area of 100% of the planar superfamily area.

12. The tissue product, as such, is claimed in Clauses 1 or 2, characterized in that the primary area has a width dimension of from about 0. to about 4 inches and the complementary delivery zone has a dimension of width from about 0.1 about 2 inches.

13. The tissue product, as claimed in clause 12, because the primary area has a width dimension of from about 0. to about 2 inches and the delivery zone has an anhous dimension of from about 0.2 about 1 inch.

14. The tissue tissue, as such, was claimed in clause 12, characterized in that the primary area has a width dimension of from about 0. to about 1.5 inches and the complementary delivery zone has a width dimension. from around 0.25 around 0.75 inches.

15. The tissue product, as claimed in clauses 1 or 2, characterized in that the zone between primary is surrounded laterally by the complementary zone.

16. The tissue produst, as claimed in Sections 1 or 2, characterized in that the zone between primary is colosada immediately to one side of the delivery zone somplementaria.

17. The tissue product, as such, is claimed in clauses 1 or 2, characterized in that the zone of primary comprises a plurality of primary delivery zones and the complementary delivery zone comprises a plurality of complementary zones.

18. The tissue product, as claimed in clauses 1 or 2, characterized in that the additive composition within each primary and complementary delivery zone comprises from about 30 to about 90% by weight oil and from about 10 to about 40% by weight wax, said somposision has a melting point of about 30 ° C to about 70 ° C.

19. The tissue produst, as such, was claimed in clause 18, characterized in that the level of primary aggregate is from about 3 to about 15% by weight and the level of complementary aggregate is from about 0.5 to about 12. % by weight.

20. The tissue product, as claimed in clause 18, characterized in that the level of primary aggregate is from about 4 to about 10% per pes and the level of complementary aggregate is from about to about 8. % by weight.

21. The tissue product, as claimed in clause 18, characterized in that it also comprises from about 5 to about 40% by weight of fatty alcohol.

22. The tissue product, as claimed in clause 18, because the sanctity of asepsis is about 40 to about 70% by weight.

23. The tissue product, as claimed in clause 18, characterized in that the sanctity of sera in somposis is from about 10 to about 30 wt.%.

24. The tissue produst, as such, is claimed in clauses 1 or 2, because the additive composition within each primary delivery zone and supplement comprises a silicone compound.

25. The tissue product, as claimed in clause 24, costerized because the level adds primary is from about 0.5 to about 3% by pe and the level of complementary aggregate is from about 0.25 to about 1.75% by weight.

26. The tissue product, as claimed in clause 24, costerized because the level adds primary is from about 0.7 to about 2% by pe and the level of aggregate is from about 0.35 to about 1% by weight.

27. The produst of tissue, as such, is claimed in clause 1, characterized in that the complementary zones include different -compositions of additives.

28. The tissue product, as claimed in clauses 1 or 2, characterized in that they comprise one or more layers of tissue dried in a continuous and not creped form.

29. A method for making a tissue product comprising: providing a tissue of tissue and an additive composition; applying the additive composition to tissue tissue using a rotogravure process comprising an etched roller having the primary and complementary regions, the primary and complementary regions are adapted to provide different aggregate rates; Y recovering from the rotogravure process a tissue product having the colosada additive composition in both the primary delivery zone that has a primary aggregate level and a somplementary delivery zone that has a supplementary aggregate level d, the aggregate level being complementary; greater than zero and from about 0.5 to about 80% of the primary aggregate level.

30. The method, as such, is claimed in Clause 29, characterized in that the primary region of the engraved roll comprises a volume of cells of about 0.5 about 15 millimeters of surplus trillion per inch suffixed and the engraved roll region comprises cells which have a cell volume of less than about 0.1 to about 10 microns of cubic trillion per square inch.

31. The method, as claimed in clause 29, is characterized in that the primary region of the engraved roll comprises a volume of cells of about 1 about 10 microns of cubic billion per square inch and the complementary region of the engraved roll comprises cells having a cell volume less than about 0.5 to about 8 microns of cubic trillion per square inch.

32. The method, as claimed in clause 29, characterized in that the primary region of the engraved rod comprises a volume of cells of about 1.5 about 8 microns of cubic billion per square inch and complementary region of the engraved roller comprises cells having a cell volume less than about 0.75 to about 6 microns of cubic trillion per square inch. E S U M E N A soft tissue product that includes deposits an additive surface composition placed in primary and complementary delivery zones that have different levels of aggregate. The level of complementary aggregate is greater than sero and less than the primary aggregate level. For example, the aggregate level can be from about 0. to about 80% of the primary aggregate level. In particular, the primary delivery areas cover from about 30 to about 90% of the tissue and the complementary delivery zones cover from about to about 70% of the tissue. The different aggregate levels effectively maximize the benefit to the consumer while minimizing the total amount of additive on the tissue. A particularly beneficial method is to uniformly apply composition to the surface of the tissue tissue within each of the zones by rotogravure printing either indirectly (offset) because it is an exact printing process and offers maximum control of composition distribution and transfer rate. However, other application methods, such as flexographic printing, spraying extrusion and the like can also be employed. An engraved roll suitable for use in applying additives to paper from you is recorded with two different regions of cell patterns.